Guiyang bureau provides services for local pharmaceutical enterprises

Leaders of the bureau answer questions asked by biopharmaceutical companies. [Photo/guiyang.gov.cn]

To help pharmaceutical enterprises benefit from an inclusive tax policy, the Guiyang bureau of science and technology recently launched "face-to-face" service activities among enterprises in various districts.

Focusing on the development of new drugs by pharmaceutical companies, the collection of research and development expenses, the reporting of research and development projects of more than 100,000 yuan ($14,350), the technical appraisal of pre-tax deduction of research and development expenses, and the cultivation of high-tech enterprises, the bureau gave detailed answers to questions asked by biopharmaceutical companies such as Weimen Pharmaceutical Co, Tianan Pharmaceutical Co, and Jianxing Pharmaceutical Co.

Sun Qianyun, researcher at the Key Laboratory of Natural Product Chemistry of the Chinese Academy of Sciences in Guizhou, was invited to provide on-site guidance to relevant pharmaceutical companies on how to refine R&D projects, highlight R&D activities, and improve application materials.

In addition, Sun gave an in-depth explanation of intellectual property declaration and application, as well as the application of scientific and technological achievements required of high-level enterprises.